Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
gptkb:Ritonavir
|
| gptkbp:approvedBy |
gptkb:COVID-19
|
| gptkbp:ATCCode |
J05AX
|
| gptkbp:CASNumber |
gptkb:1496510-51-0
|
| gptkbp:component |
gptkb:Paxlovid
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:hasInChIKey |
DBDRLJTVLORXQP-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C23H32F3N5O4
|
| gptkbp:hasSMILES |
CC1(CNC(=O)C(NC(=O)C(F)(F)F)C2CC2)C(=O)N(C1=O)CC3CCNC3=O
|
| gptkbp:hasTherapeuticUse |
antiviral
|
| gptkbp:hasUNII |
QHU4B1DV9N
|
| https://www.w3.org/2000/01/rdf-schema#label |
1496510-51-0
|
| gptkbp:molecularWeight |
499.5 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL4297599
gptkb:DB16335 155903259 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:PF-07321332
gptkb:Nirmatrelvir |
| gptkbp:target |
gptkb:SARS-CoV-2_main_protease
|
| gptkbp:bfsParent |
gptkb:Relacorilant
|
| gptkbp:bfsLayer |
8
|